chartexchange

Caribou Biosciences Reports Q3 2026 Revenue of $1.6 Million and Loss Per Share of $0. ...

GuruFocus | Nov 5, 2026 6:10 PM EST

Revenue of $1.6 Million Meets Estimates, While Restructuring and Clinical Program Wind-Down Reshape the Company's Outlook Related Stocks: CRBU ,

Read original article